Pfizer (NYSE:PFE) has been dismissed as a defendant in a major federal lawsuit alleging generic drug price fixing. The court ...
Demand for GLP-1 drugs such as semaglutide is exposing capacity gaps across peptide APIs, sterile fill-finish facilities, ...
FDA takes an industry-friendly approach; Trump aide in consideration to lead FDA; Biotech CEOs are suddenly bullish.
Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has ...
Dr Reddy's whitepaper says weak translational research ecosystem is slowing the journey from laboratory breakthroughs to ...
M upfront, up to $1.8B milestones, and what it signals for NVS amid patent cliffs. Click for this look at the deal.
Teplizumab is an immunotherapy drug designed to modify the immune system's response. Instead of simply treating symptoms, it ...
Teplizumab is an immunotherapy drug designed to modify the immune system's response. Instead of simply treating symptoms, it ...
Teens increasingly have mental health issues, schools are trying to keep up. School psychologists are costly. LLMs can be an ...
"The Orphan Designation for ODM-212 is an important milestone for Orion Pharma. It highlights the need for new treatments in mesothelioma and reinforces our commitment to developing innovative ...
Acquisition adds YUPELRI®(revefenacin), the first and only approved nebulized long-acting muscarinic antagonist (LAMA) for the maintenance treatment of COPD to Zymeworks' portfolioAcquisition of ...
The Mission Biopharma SHAKTI scheme, launched in 2026-27, marks an important step in promoting biologics and biosimilars ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results